Need professional-grade analysis? Visit stockanalysis.com
$39.33B
31.89
37,900
3.50%
Price Chart
Risk-Adjusted Performance
Reckitt Benckiser Group PLC (RKT) Price Performance
Reckitt Benckiser Group PLC (RKT) trades on London Stock Exchange in GBX. The company is classified in the Consumer Defensive sector under the Household & Personal Products industry. The stock currently trades at GBX5110.00, up 0.27% from the previous close.
Over the past year, RKT has traded between a low of GBX4561.76 and a high of GBX6512.00. The stock has gained 2.8% over this period. It is currently 21.5% below its 52-week high.
Reckitt Benckiser Group PLC has a market capitalization of $39.33B, with a price-to-earnings ratio of 31.89 and a dividend yield of 3.50%.
About Reckitt Benckiser Group PLC
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom and internationally. The company offers germ protection under Dettol name; intimate wellness under Durex and KY brand names; over the counter under the Biofreeze, Gaviscon, Mucinex, Nurofen, and Strepsils names. It also provides personal care products under Clearasil and Veet brand names; vitamins, minerals, and supplements under Airborne, Movefree, and neuriva names; and disinfectant products under the Finish, Harpic, and Lysol brands. In addition, the company offers nutritious complementary foods and milk formulas for infant and young children under the Enfamil and Nutramigen brands. Reckitt Benckiser Group plc was founded in 1819 and is headquartered in Slough, the United Kingdom.
Company Info
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Exchange
- London Stock Exchange
- Currency
- GBX
- Country
- United Kingdom
Financial Metrics
- Revenue (TTM)
- $13.98B
- EBITDA
- $3.56B
- Profit Margin
- 8.88%
- EPS (TTM)
- 1.83
- Book Value
- 9.29
Technical Indicators
- 52 Week High
- GBX 6,514.00
- 52 Week Low
- GBX 4,515.81
- 50 Day MA
- GBX 5,758.76
- 200 Day MA
- GBX 5,301.59
- Beta
- 0.09
Valuation
- Trailing P/E
- 31.89
- Forward P/E
- 14.75
- Price/Sales
- 2.43
- Price/Book
- 5.47
- Enterprise Value
- $42.87B